Key Defenses in the Pandemic

How to Strengthen Your Immune System and Protect Others during the Pandemic

Explore Your Topic

We Need More Screen Time — No, Not That Kind

Interview with Robert S. Greene

Prostate Cancer: “the Treatment Conversation Needs to Start with Quality of Life”

Extremely Normal

A Very 2020 Look at Food, Climate Change and Extreme Weather

Our Products

Can We Live Better?

Can 10 billion of us live better?

Working together for Health for all, Hunger for none

Finding Heart: Women and Cardiovascular Risk

Uses and Safety Record

Let’s Talk About Glyphosate

Links

Information for Patients

Modern Slavery Act Statement.pdf (PDF 2.05 MB)

Latest News

Share Price / Index

December 1, 2020 17:39 CEST

December 1, 2020 17:45 CEST

November 17, 2020

Not intended for U.S. and UK Media - Late-Breaking Data from subgroup analysis of Phase III FIDELIO-DKD study presented at the American Heart Association (AHA) Scientific Sessions 2020

Finerenone showed consistent benefits on cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes with or without history of cardiovascular disease

November 13, 2020

Not intended for U.S. and UK Media

Positive CHMP opinion for extension of rivaroxaban marketing authorization to treat venous thromboembolism (VTE) in children

November 12, 2020

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

Advance Your Career

Why Bayer

Working at Bayer

Meet Our Employees

Open Jobs

Reliabilityexperte (m/w/d)

Elektroniker im Verpackungsbetrieb flüssiger Arzneiformen (m/w/d)

Senior Expert Chemical Safety (m/f/d)

Germany Leverkusen

Explore Our Businesses

We address some of the world's most pressing global challenges and continue to develop new solutions. The population is constantly growing and its age is increasing. That is why it needs better medicines and high-quality food in sufficient quantities. Learn more about it here.

Pharmaceuticals

Consumer Health